Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:21 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term

ClinicalTrials.gov · NCT02416583 · Registry updated: 2020-03-03

Condition / research focus: Failed Induction of Labor
Sponsor: Seoul National University Hospital
Countries with listed sites: South Korea
Registry dates and results: Start: 2015-04. Completion: 2018-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Dinoprostone (drug)
Membrane sweeping (procedure)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Department of Obstetrics and Gynecology Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders

ClinicalTrials.gov · NCT01337687 · Registry updated: 2020-02-27

Condition / research focus: Autism Spectrum Disorders
Sponsor: Montefiore Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2009-10. Completion: 2013-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Montefiore Medical Center, Albert Einstein College of Medicine
The Bronx, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Adult Study Oxytocin - Behavioral

ClinicalTrials.gov · NCT02567032 · Registry updated: 2020-02-26

Condition / research focus: Schizophrenia; Oxytocin; Social Cognition; Psychotic Disorders
Sponsor: University of California, San Francisco
Countries with listed sites: United States
Registry dates and results: Start: 2010-10. Completion: 2019-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Saline Nasal Spray (drug) — also listed as: Placebo

Where the study takes place — 2 listed sites

San Francisco Veterans Affairs Medical Center
San Francisco, California, United States
Site recruitment: Not reported
University of California, San Francisco
San Francisco, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study

ClinicalTrials.gov · NCT03339024 · Registry updated: 2020-02-19

Condition / research focus: Alcoholism; Substance-Related Disorders
Sponsor: Norwegian University of Science and Technology
Countries with listed sites: Norway
Registry dates and results: Start: 2017-11-01. Completion: 2019-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin spray (drug) — also listed as: Syntocinon
intranasal spray without oxytocin (other) — also listed as: placebo

Where the study takes place — 1 listed sites

Lade Addiction Treatment Center
Trondheim, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

ClinicalTrials.gov · NCT03957083 · Registry updated: 2020-02-06

Condition / research focus: Postpartum Hemorrhage; Obesity
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2019-06-26. Completion: 2020-02-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Outpatient Foley For Starting Induction of Labor at Term in Nulliparous Women

ClinicalTrials.gov · NCT03472937 · Registry updated: 2020-02-06

Condition / research focus: Pregnancy Related
Sponsor: University of Alabama at Birmingham
Countries with listed sites: United States
Registry dates and results: Start: 2018-05-04. Completion: 2019-12-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transcervical Foley catheter placement for cervical ripening (procedure)

Where the study takes place — 1 listed sites

University of Alabama at Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin

ClinicalTrials.gov · NCT03640156 · Registry updated: 2020-02-05

Condition / research focus: Autism Spectrum Disorder
Sponsor: KU Leuven
Countries with listed sites: Belgium
Registry dates and results: Start: 2018-07-26. Completion: 2019-12-19 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon (product code RVG 03716)
Placebo (other)

Where the study takes place — 1 listed sites

Katholieke Universiteit Leuven
Leuven, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

OTR Tablet 10 mg Fasted-state Bioequivalence Study

ClinicalTrials.gov · NCT03403504 · Registry updated: 2020-01-31

Condition / research focus: Chronic Pain
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Countries with listed sites: China
Registry dates and results: Start: 2017-02-01. Completion: 2017-09-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxycodone Tamper Resistant (drug) — also listed as: Oxycodone Tamper Resistant (OTR) Tablet 10 mg
OXYCONTIN® (drug) — also listed as: OXYCONTIN® Tablet 10 mg

Where the study takes place — 1 listed sites

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Shenyang, Liaoning, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

OTR Tablet 40 mg Fasted-state Bioequivalence Study

ClinicalTrials.gov · NCT03398278 · Registry updated: 2020-01-31

Condition / research focus: Chronic Pain
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Countries with listed sites: China
Registry dates and results: Start: 2017-06-30. Completion: 2018-03-20 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxycodone Tamper Resistant (drug) — also listed as: Oxycodone Tamper Resistant (OTR) Tablet 40 mg
OXYCONTIN® (drug) — also listed as: OXYCONTIN® Tablet 40 mg

Where the study takes place — 1 listed sites

West Hospital, Sichuan University
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes

ClinicalTrials.gov · NCT04143685 · Registry updated: 2020-01-29

Condition / research focus: Prelabor Rupture of Membranes; Premature Rupture of Membrane
Sponsor: sammour.rami
Countries with listed sites: Israel
Registry dates and results: Start: 2019-12-01. Completion: 2021-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec, PGE1
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Bnai Zion Medical Center
Haifa, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder

ClinicalTrials.gov · NCT01914939 · Registry updated: 2020-01-27

Condition / research focus: Autism Spectrum Disorders
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2014-04. Completion: 2017-11 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Social Skills focused CBT (behavioral)
Stress management/relaxation training (behavioral)
placebo drug (drug)

Where the study takes place — 2 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported
Massachusetts Institute of Technology Martinos Imaging Center
Cambridge, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean

ClinicalTrials.gov · NCT03693599 · Registry updated: 2020-01-03

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-10-01. Completion: 2019-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin (drug)
Syntometrine (drug)

Where the study takes place — 1 listed sites

faculty of medicine Cairo university
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

A Trial of TTA-121 on Autism Spectrum Disorder

ClinicalTrials.gov · NCT03466671 · Registry updated: 2019-12-20

Condition / research focus: Autism Spectrum Disorder
Sponsor: Hamamatsu University
Countries with listed sites: Japan
Registry dates and results: Start: 2018-02-27. Completion: 2020-03-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TTA-121 (drug)

Where the study takes place — 1 listed sites

Hamamatsu University School of Medicine
Hamamatsu, Shizuoka, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Brain Imaging Study of Adults With Autism Spectrum Disorders

ClinicalTrials.gov · NCT01093768 · Registry updated: 2019-12-17

Condition / research focus: Autism Spectrum Disorders
Sponsor: National Institute of Mental Health (NIMH)
Countries with listed sites: United States
Registry dates and results: Start: 2010-02-19. Completion: 2013-04-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Vasopressin (drug)

Where the study takes place — 1 listed sites

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Early Versus Delayed Oxytocin Infusion Following Amniotomy in Nulliparous Women

ClinicalTrials.gov · NCT04200599 · Registry updated: 2019-12-16

Condition / research focus: Delivery Delayed; Mode of Delivery; Post Partum Hemorrhage; Uterine Hyperstimulation
Sponsor: National University of Malaysia
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-08-01. Completion: 2016-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

duration of initiation of oxytocin (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia

ClinicalTrials.gov · NCT02144155 · Registry updated: 2019-12-09

Condition / research focus: Schizophrenia
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2012-03. Completion: 2014-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin: 24IU - 168 IU (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

UCSD Medical Center - Hillcrest
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1TerminatedINTERVENTIONAL

Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility

ClinicalTrials.gov · NCT02908126 · Registry updated: 2019-11-22

Condition / research focus: Post Partum Haemorrhage
Sponsor: Oxytone Bioscience BV
Countries with listed sites: Sweden
Registry dates and results: Start: 2018-04-03. Completion: 2019-06-27 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

Karolinska Institute, Danderyd hospital,Dept of Obstetrics and Gynecology
Stockholm, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Antipsychotic Effects of Oxytocin

ClinicalTrials.gov · NCT01621737 · Registry updated: 2019-11-19

Condition / research focus: Schizophrenia
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2011-06. Completion: 2018-12 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Oxytocin (drug)
Placebo (drug)

Where the study takes place — 2 listed sites

University of California, Irvine
Irvine, California, United States
Site recruitment: Not reported
University of California, San Diego
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

OTR Tablet 40 mg Fed-state Bioequivalence Study

ClinicalTrials.gov · NCT03398330 · Registry updated: 2019-11-15

Condition / research focus: Chronic Pain
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Countries with listed sites: China
Registry dates and results: Start: 2017-03-16. Completion: 2017-11-06 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxycodone Tamper Resistant (drug) — also listed as: Oxycodone Tamper Resistant (OTR) Tablet
OxyContin® (drug) — also listed as: OXYCONTIN® Tablet 40 mg

Where the study takes place — 1 listed sites

Xiangya Hospital of Central South University
Changsha, Hunan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Influence of Oxytocin on Romantic Jealousy

ClinicalTrials.gov · NCT03067805 · Registry updated: 2019-11-14

Condition / research focus: Sexual Infidelity; Emotional Infidelity; Jealousy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-02. Completion: 2019-05 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sexual Infidelity Condition (behavioral)
Emotional Infidelity Condition (behavioral)
Neutral Condition (behavioral)
Player in Jealousy Condition (behavioral)
Player in Non-Jealousy Condition (behavioral)

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:21 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term

ClinicalTrials.gov · NCT02416583 · Registry updated: 2020-03-03

Condition / research focus: Failed Induction of Labor
Sponsor: Seoul National University Hospital
Countries with listed sites: South Korea
Registry dates and results: Start: 2015-04. Completion: 2018-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Dinoprostone (drug)
Membrane sweeping (procedure)

Where the study takes place — 1 listed sites

Department of Obstetrics and Gynecology Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders

ClinicalTrials.gov · NCT01337687 · Registry updated: 2020-02-27

Condition / research focus: Autism Spectrum Disorders
Sponsor: Montefiore Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2009-10. Completion: 2013-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Montefiore Medical Center, Albert Einstein College of Medicine
The Bronx, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Adult Study Oxytocin - Behavioral

ClinicalTrials.gov · NCT02567032 · Registry updated: 2020-02-26

Condition / research focus: Schizophrenia; Oxytocin; Social Cognition; Psychotic Disorders
Sponsor: University of California, San Francisco
Countries with listed sites: United States
Registry dates and results: Start: 2010-10. Completion: 2019-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Saline Nasal Spray (drug) — also listed as: Placebo

Where the study takes place — 2 listed sites

San Francisco Veterans Affairs Medical Center
San Francisco, California, United States
Site recruitment: Not reported
University of California, San Francisco
San Francisco, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study

ClinicalTrials.gov · NCT03339024 · Registry updated: 2020-02-19

Condition / research focus: Alcoholism; Substance-Related Disorders
Sponsor: Norwegian University of Science and Technology
Countries with listed sites: Norway
Registry dates and results: Start: 2017-11-01. Completion: 2019-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin spray (drug) — also listed as: Syntocinon
intranasal spray without oxytocin (other) — also listed as: placebo

Where the study takes place — 1 listed sites

Lade Addiction Treatment Center
Trondheim, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

ClinicalTrials.gov · NCT03957083 · Registry updated: 2020-02-06

Condition / research focus: Postpartum Hemorrhage; Obesity
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2019-06-26. Completion: 2020-02-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Outpatient Foley For Starting Induction of Labor at Term in Nulliparous Women

ClinicalTrials.gov · NCT03472937 · Registry updated: 2020-02-06

Condition / research focus: Pregnancy Related
Sponsor: University of Alabama at Birmingham
Countries with listed sites: United States
Registry dates and results: Start: 2018-05-04. Completion: 2019-12-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transcervical Foley catheter placement for cervical ripening (procedure)

Where the study takes place — 1 listed sites

University of Alabama at Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin

ClinicalTrials.gov · NCT03640156 · Registry updated: 2020-02-05

Condition / research focus: Autism Spectrum Disorder
Sponsor: KU Leuven
Countries with listed sites: Belgium
Registry dates and results: Start: 2018-07-26. Completion: 2019-12-19 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon (product code RVG 03716)
Placebo (other)

Where the study takes place — 1 listed sites

Katholieke Universiteit Leuven
Leuven, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

OTR Tablet 10 mg Fasted-state Bioequivalence Study

ClinicalTrials.gov · NCT03403504 · Registry updated: 2020-01-31

Condition / research focus: Chronic Pain
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Countries with listed sites: China
Registry dates and results: Start: 2017-02-01. Completion: 2017-09-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxycodone Tamper Resistant (drug) — also listed as: Oxycodone Tamper Resistant (OTR) Tablet 10 mg
OXYCONTIN® (drug) — also listed as: OXYCONTIN® Tablet 10 mg

Where the study takes place — 1 listed sites

The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Shenyang, Liaoning, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

OTR Tablet 40 mg Fasted-state Bioequivalence Study

ClinicalTrials.gov · NCT03398278 · Registry updated: 2020-01-31

Condition / research focus: Chronic Pain
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Countries with listed sites: China
Registry dates and results: Start: 2017-06-30. Completion: 2018-03-20 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxycodone Tamper Resistant (drug) — also listed as: Oxycodone Tamper Resistant (OTR) Tablet 40 mg
OXYCONTIN® (drug) — also listed as: OXYCONTIN® Tablet 40 mg

Where the study takes place — 1 listed sites

West Hospital, Sichuan University
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes

ClinicalTrials.gov · NCT04143685 · Registry updated: 2020-01-29

Condition / research focus: Prelabor Rupture of Membranes; Premature Rupture of Membrane
Sponsor: sammour.rami
Countries with listed sites: Israel
Registry dates and results: Start: 2019-12-01. Completion: 2021-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec, PGE1
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Bnai Zion Medical Center
Haifa, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder

ClinicalTrials.gov · NCT01914939 · Registry updated: 2020-01-27

Condition / research focus: Autism Spectrum Disorders
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2014-04. Completion: 2017-11 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Social Skills focused CBT (behavioral)
Stress management/relaxation training (behavioral)
placebo drug (drug)

Where the study takes place — 2 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported
Massachusetts Institute of Technology Martinos Imaging Center
Cambridge, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean

ClinicalTrials.gov · NCT03693599 · Registry updated: 2020-01-03

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-10-01. Completion: 2019-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin (drug)
Syntometrine (drug)

Where the study takes place — 1 listed sites

faculty of medicine Cairo university
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

A Trial of TTA-121 on Autism Spectrum Disorder

ClinicalTrials.gov · NCT03466671 · Registry updated: 2019-12-20

Condition / research focus: Autism Spectrum Disorder
Sponsor: Hamamatsu University
Countries with listed sites: Japan
Registry dates and results: Start: 2018-02-27. Completion: 2020-03-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TTA-121 (drug)

Where the study takes place — 1 listed sites

Hamamatsu University School of Medicine
Hamamatsu, Shizuoka, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Brain Imaging Study of Adults With Autism Spectrum Disorders

ClinicalTrials.gov · NCT01093768 · Registry updated: 2019-12-17

Condition / research focus: Autism Spectrum Disorders
Sponsor: National Institute of Mental Health (NIMH)
Countries with listed sites: United States
Registry dates and results: Start: 2010-02-19. Completion: 2013-04-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Vasopressin (drug)

Where the study takes place — 1 listed sites

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Early Versus Delayed Oxytocin Infusion Following Amniotomy in Nulliparous Women

ClinicalTrials.gov · NCT04200599 · Registry updated: 2019-12-16

Condition / research focus: Delivery Delayed; Mode of Delivery; Post Partum Hemorrhage; Uterine Hyperstimulation
Sponsor: National University of Malaysia
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-08-01. Completion: 2016-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

duration of initiation of oxytocin (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia

ClinicalTrials.gov · NCT02144155 · Registry updated: 2019-12-09

Condition / research focus: Schizophrenia
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2012-03. Completion: 2014-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin: 24IU - 168 IU (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

UCSD Medical Center - Hillcrest
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1TerminatedINTERVENTIONAL

Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility

ClinicalTrials.gov · NCT02908126 · Registry updated: 2019-11-22

Condition / research focus: Post Partum Haemorrhage
Sponsor: Oxytone Bioscience BV
Countries with listed sites: Sweden
Registry dates and results: Start: 2018-04-03. Completion: 2019-06-27 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

Karolinska Institute, Danderyd hospital,Dept of Obstetrics and Gynecology
Stockholm, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Antipsychotic Effects of Oxytocin

ClinicalTrials.gov · NCT01621737 · Registry updated: 2019-11-19

Condition / research focus: Schizophrenia
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2011-06. Completion: 2018-12 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Oxytocin (drug)
Placebo (drug)

Where the study takes place — 2 listed sites

University of California, Irvine
Irvine, California, United States
Site recruitment: Not reported
University of California, San Diego
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

OTR Tablet 40 mg Fed-state Bioequivalence Study

ClinicalTrials.gov · NCT03398330 · Registry updated: 2019-11-15

Condition / research focus: Chronic Pain
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Countries with listed sites: China
Registry dates and results: Start: 2017-03-16. Completion: 2017-11-06 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxycodone Tamper Resistant (drug) — also listed as: Oxycodone Tamper Resistant (OTR) Tablet
OxyContin® (drug) — also listed as: OXYCONTIN® Tablet 40 mg

Where the study takes place — 1 listed sites

Xiangya Hospital of Central South University
Changsha, Hunan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Influence of Oxytocin on Romantic Jealousy

ClinicalTrials.gov · NCT03067805 · Registry updated: 2019-11-14

Condition / research focus: Sexual Infidelity; Emotional Infidelity; Jealousy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2016-02. Completion: 2019-05 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sexual Infidelity Condition (behavioral)
Emotional Infidelity Condition (behavioral)
Neutral Condition (behavioral)
Player in Jealousy Condition (behavioral)
Player in Non-Jealousy Condition (behavioral)

Where the study takes place — 1 listed sites

School of Life Science and Technology, University of Electronic Science and Technology
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →